ExodusPoint Capital Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$341K	Sell	95,180 -83,746	-47%	-$333K	﹤0.01%	1282
2025 Q4	$628K	Sell	178,926 -63,258	-26%	-$217K	0.01%	1133
2025 Q3	$790K	Buy	242,184 +77,147	+47%	+$243K	0.01%	1042
2025 Q2	$404K	Sell	165,037 -35,647	-18%	-$181K	﹤0.01%	1197
2025 Q1	$1.34M	Buy	200,684 +10,805	+6%	+$107K	0.02%	835
2024 Q4	$2.39M	Buy	189,879 +124,261	+189%	+$1.87M	0.02%	659
2024 Q3	$1.21M	Buy	+65,618	New	+$1.34M	0.01%	917
2023 Q3	–	Sell	-34,798	Closed	-$691K	–	2071
2023 Q2	$691K	Sell	34,798 -271,264	-89%	-$5.48M	0.01%	1237
2023 Q1	$5.24M	Buy	+306,062	New	+$5.99M	0.06%	497
2022 Q4	–	Sell	-37,402	Closed	-$597K	–	2047
2022 Q3	$597K	Buy	37,402 +19,727	+112%	+$308K	0.01%	1301
2022 Q2	$243K	Sell	17,675 -2,819	-14%	-$33.6K	﹤0.01%	1605
2022 Q1	$325K	Buy	+20,494	New	+$354K	﹤0.01%	1730
2021 Q1	–	Sell	-36,085	Closed	-$1.98M	–	2529
2020 Q4	$1.98M	Buy	36,085 +6,516	+22%	+$238K	0.03%	546
2020 Q3	$676K	Buy	+29,569	New	+$729K	0.02%	861
2020 Q1	–	Sell	-31,054	Closed	-$707K	–	1550
2019 Q4	$707K	Buy	31,054 +18,454	+146%	+$308K	0.02%	690
2019 Q3	$147K	Buy	+12,600	New	+$156K	0.01%	1188

Other funds holding RCKT